This unique collection of trademark transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2021-01-27
Record Count: 10
- Personal Care Products
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 651
'Normothermic Use' means use (excluding Total Body Washout) of the Product in surgical or therapeutic procedures in which the patient's body temperature is 12 degrees Centigrade or higher.
Hydroxyethyl Starch (High
Molecular Weight Hetastarch) 6%
Sodium Chloride 115 millimoles/liter
Magnesium Chloride Hexahydrate 0.45 millimoles/liter
Calcium Chloride Dihydrate 2.5 millimoles/liter
Potassium Chloride 3 millimoles/liter
Glucose 5 millimoles/liter
Sodium Lactate 28 millimoles/liter
IPSCIO Record ID: 256627
Japanese Licensor grants an exclusive license, with the right to grant sublicenses, under the Licensed IP Rights to conduct research and to develop, make, have made, use, offer for sale, sell and import Products in the Territory for use in the Field 1, and Field 2.
The licensed patents refer to manufacturing method for preparing benzoic acid derivatives and Polymorphism.
Field 1 shall mean the pharmaceutical prevention or treatment in humans of the following indications: acute promyelocytic leukemia (APL).
Field 2 shall mean the pharmaceutical prevention or treatment in humans of the following indications: multiple myeloma (MM), myelodysplatic syndrome (MDS), and all solid tumor indications and Field shall collectively mean Field 1 and Field 2.
IPSCIO Record ID: 245916
Trademark is ONECTYL(R)
Compound shall mean VINORELBINE (INN), a vinca alkaloid derivative.
IPSCIO Record ID: 27159
'Compound' shall mean Modafinil and/or other compounds, isomers or salts thereof.
Modafinil compound is the active drug substance contained for use by those suffering from excessive daytime sleepiness associated with narcolepsy.
IPSCIO Record ID: 288913
IPSCIO Record ID: 400
IPSCIO Record ID: 26450
Licensor is a multinational health care with a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products.
IPSCIO Record ID: 223134
Licensor and Licensee shall mutually agree upon one or more trademarks under which Licensee, its Affiliates and sub-licensees will exclusively market the Licensed Products (the 'Trademarks') in the Licensed Territory. Licensor shall own and shall retain the ownership of the entire right, title and interest in and to the Trademarks.
Licensor is a French multinational pharmaceutical and cosmetics company.
IPSCIO Record ID: 203381
– An exclusive license, even as to Licensor, to use the Product Trademarks in connection with the Commercialization of Licensed Products in the Territory; and
– A non-exclusive license to use Designated Licensor Trademarks.
â€œDesignated Licensor Trademarkâ€
Licensor is a pharmaceutical company focused on transforming medicines that can transform lives.
IPSCIO Record ID: 3839
Trademark' shall mean the mark 'Prevent-X,' any modification, variation or designation of origin that is confusingly similar thereto.
â€œGel Productâ€ shall mean the spermicide and microbicide contraceptive gel product embodying the Formulation presently being developed by IBC, also known as the GEDA Plus product, designed to prevent the transmission of sexually transmitted diseases including, but not limited to, gonorrhea, chlamydia, syphilis, Trichomonas, herpes I and II and HIV, and which is presently undergoing the appropriate and necessary United States governmental regulatory compliance process to permit Empyrean to include such product as a Licensed Product hereunder.
â€œLotion Productsâ€ (also known as GEDA Lotion) shall mean the hand sanitizing lotion.